<header id=051235>
Published Date: 2022-09-09 20:46:49 EDT
Subject: PRO/EDR> Poliomyelitis update (38): VDPV, USA, UK, comment
Archive Number: 20220910.8705506
</header>
<body id=051235>
POLIOMYELITIS UPDATE (38): VACCINE DERIVED POLIOVIRUS, USA (NEW YORK), UK (LONDON), COMMENT
*******************************************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: Fri 9 Sep 2022
From: T Jacob John [edited]
<tjacobjohn@yahoo.co.in>


An observation: circulating vaccine-derived poliovirus type 2 [cVDPV2] is wild-like, having acquired neurovirulence and transmission efficiency through mutations. The sustained prevalence in London and New York over several months is indicative of local spread among the population. The route of transmission cannot be faecal-oral on account of high standards of sanitation and hygiene. It stands to reason that transmission route is respiratory. Since cVDPV is wild-like, the route of transmission of wild polioviruses also is likely to be respiratory and not faecal-oral as assumed by many polio experts. In fact there is evidence for respiratory transmission, but none at all for faecal-oral transmission (Martinez-Bakkar M et al. Unravellling the transmission ecology of polio. PLoS Biol 2015; 13(6) e1002172. doi 10.1371/journal.Pbio.1002172). The policy of exclusive use of OPV for eradication was based on the assumption of faecal-oral transmission of wild polioviruses. IPV has very high protective efficacy against polio (as demonstrated in real-life in London and New York) and is more effective in retarding respiratory transmission than OPV. Children in low income countries deserve IPV for protection against cVDPV2 polio that has been occurring as outbreaks in some 35 countries.

--
Communicated by:
T Jacob John
Christian Medical College, Vellore, India (Retired)
<tjacobjohn@yahoo.co.in>

[It is always a pleasure to receive comments from Prof. T Jacob John. Oral pharyngeal infection occurs 1st, and with tonsillar tissue infected, it is logical to see oraI-phayngeal to oral pharyngeal transmission of the virus in the early days of infection. I for one also agree with the need to rethink the vaccine policy globally, especially in the face of cVDPV outbreaks in a multitude of countries around the world.

One of the best proofs of IPV efficacy in preventing paralytic disease was the transmission of the WPV1 through Israel starting in the south going up to the north in 2013. (see Poliomyelitis update (19): Somalia, Israel, global 20130817.1884992; Poliomyelitis update (18): Israel 20130807.1869032; Poliomyelitis update (16): Israel, Somalia, global 20130801.1854632; Poliomyelitis update (14): Israel, environmental samples, global 20130715.1826123; Poliomyelitis update (12): Kenya, Somalia, RFI, Israel environ. samples 20130614.1772461; Poliomyelitis update (10): Israel, positive environmental samples, MOH 20130605.1756289; Poliomyelitis update (09): Israel, positive environmental samples, RFI 20130604.1754766; Poliomyelitis update (08): Israel, environmental isolates, WHO, RFI 20130603.1753099).

Prior to that event Israel had been using only IPV vaccine. A booster dose of bivalent OPV (containing OPV1 and OPV3) was added following the transmission of WPV1. Note that there were no paralytic cases associated with that event in 2013. In early 2022, Israel documented a paralytic case associated with a cVDPV3 virus (see below for links to prior posts).

Looking at the Global Polio Eradication charts on virus isolates from paralytic cases and environmental sampling, one sees that there have been positive environmental samples (ESs) for cVDPV3 in Israel beginning in 2020 (1 isolate), with 3 isolates in 2021 and 2 in 2022, in addition to the casae of acute flaccid paralysis in March 2022. (see https://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/). The Palestinian Authority has reported 7 ESs positive for cVDPV3 in 2021 and 1 in 2022/. - Mod.MPP

ProMED maps:
United States: https://promedmail.org/promed-post?place=8705506,106
United Kingdom: https://promedmail.org/promed-post?place=8705506,40]
See Also
Poliomyelitis update (37): WPV1 AFP (Pakistan), cVDPV1 AFP (Mozambique), cVDPV2 20220908.8705460
Poliomyelitis update (36): WPV1 AFP, ES cVDPV2 AFP, ES, USA cVDPV2 20220904.8705396
Poliomyelitis update (35): VDPV2 ES (USA, UK, Israel), global WPV1, cVDPV1, cVDPV2 20220813.8705016
Poliomyelitis update (34): WPV1 AFP, cVDPV1 ES, cVDPV2 ES, VDPV ES 20220806.8704903
Poliomyelitis update (33): WPV1 AFP (Pakistan, Mozambique) cVDPV1 AFP, VDPV2 ES 20220729.8704736
Poliomyelitis update (32): WPV1 AFP (Pakistan) 20220728.8704718
Poliomyelitis update (31): WPV1 AFP (Pakistan), VDPV2 (USA), cVDPV2 (Nigeria, Yemen) 20220723.8704617
Poliomyelitis update (30): VDPV2 AFP (USA) 20220722.8704588
Poliomyelitis update (29): WPV1 ES (Pakistan) VDPV2 (new country Algeria) WHO 20220715.8704423
Poliomyelitis update (28): WPV1 AFP (Pakistan), IHR meeting 20220625.8704083
Poliomyelitis update (27): WPV1 AFP (2 countries), VDPV2 (UK), global cVDPV AFP 20220625.8704068
Poliomyelitis update (26): VDPV2 (UK) ES 20220622.8704024
Poliomyelitis update (25): WPV1 AFP (Pakistan), cVDPV1, cVDPV2 AFP & ES multiple 20220612.8703818
Poliomyelitis update (24): WPV1 AFP (Pakistan) 20220605.8703689
Poliomyelitis update (23): WPV1 AFP (Pakistan), cVDPV2 AFP (Congo DR) 20220603.8703660
Poliomyelitis update (22): WPV1 AFP Pakistan (KP) 20220529.8703535
Poliomyelitis update (21): WPV1 AFP Pakistan, cVDPV2 multiple 20220527.8703488
Poliomyelitis update (20): WPV1 AFP Mozambique, cVDPV2, comment 20220519.8703366
Poliomyelitis update (19): WPV1 AFP Mozambique ex Pakistan 20220518.8703340
Poliomyelitis update (18): WPV1 AFP Pakistan, cVDPV2 AFP, CVDPV3, violence 20220518.8703319
Poliomyelitis update (17): Pakistan WPV1, global cVDPV2, CVDPV3 20220503.8702966
Poliomyelitis update (16): WPV1 AFP Pakistan, cVDPV2, AFP, cVDPV3 ES 20220425.8702827
Poliomyelitis update (15): cVDPV2 (AFP DR Congo, Nigeria, Yemen) comment 20220401.8702339
Poliomyelitis update (14): Israel, RFI 20220331.8702310
Poliomyelitis update (13): cVDPV2 (AFP Niger,Nigeria,Yemen), cVDPV3 (Israel) 20220326.8702235
Poliomyelitis update (12): global cVDPV2 (DR Congo, Nigeria), cVDPV3 (Israel) 20220321.8702116
Poliomyelitis update (11): global cVDPV2, cVDPV3, RFI 20220311.8701925
Poliomyelitis update (10): Israel (JM) VDPV, RFI 20220309.8701883
Poliomyelitis update (09): Israel (JM) VDPV, MOH, RFI 20220307.8701864
Poliomyelitis update (08): Malawi WPV1, WHO 20220305.8701806
Poliomyelitis update (07): global AFP, cVDPV1 (Madagascar) cVDPV2 (ES Nigeria) 20220304.8701782
Poliomyelitis update (06): global AFP, WPV1, cVDPV1 & cVDPV2, RFI 20220226.8701660
Poliomyelitis update (05): Guinea-Bissau, cVDPV, RFI 20220218.8701539
Poliomyelitis update (04): cVDPV2 (Mozambique, Nigeria, Somalia), WPV1 Malawi 20220218.8701529
Poliomyelitis update (03): WPV1 (AFP Afghanistan), cVDPV2 (AFP; ES Djibouti) 20220212.8701429
Poliomyelitis update (02): global cVDPV1 (ES Madagascar), cVDPV2 (multicountry), 2021 20220129.8701140
Poliomyelitis update (01): WPV1 (ES), cVDPV1+2 (AFP) 2021, COVID 20220103.8700644
2021
----
Poliomyelitis update (25): global cVDPV2 (multicountry) Pakistan violence 20211218.8700356
Poliomyelitis update (24): Yemen, WHO, comment 20211211.8700196
Poliomyelitis update (23): global (WPV1 Afghanistan, cVDPV2 Cameroon, Nigeria) 20211210.8700170
Poliomyelitis update (22): global (WPV1 Afghanistan, cVDPV2 multicountry), IHR 20211129.8699938
Poliomyelitis update (21): global (WPV1 Pakistan ES, cVDPV2 multicountry) 20210904.8644347
Poliomyelitis update (20): global (WPV1, cVDPV2, cVDPV1), Gambia, Uganda 20210821.8612882
Poliomyelitis update (19): global (cVDPV2) Gambia, Pakistan, RFI 20210813.8591368
Poliomyelitis update (18): global (WPV1,cVDPV1,cVDPV2), Pakistan violence 20210808.8577968
Poliomyelitis update (17): global(cVDPV1,cVDPV2 Uganda/Gambia) Pakistan, Nigeria 20210730.8557717
Poliomyelitis update (16): global (cVDPV1, cVDPV2), Nigeria 20210722.8538466
Poliomyelitis update (15): global (cVDPV2), Nigeria 20210715.8522150
Poliomyelitis update (14): Global (WPV1 ES, cVDPV2, cVDPV1) 20210708.8505008
Poliomyelitis update (13): global (cVDPV2 Nigeria, Egypt environmental sample) 20210702.8489890
Poliomyelitis update (12): global (cVDPV2, WPV1 ES) 20210624.8473119
Poliomyelitis update (11): global (cVDPV2), vaccinator violence 20210618.8456569
Poliomyelitis update (10): Senegal, cVDPV2 20210614.8447598
Poliomyelitis update (09): global (WPV1 ES, cVDPV2 AFP cases) RFI 20210611.8442001
Poliomyelitis update (08): global (cVDPV2), Afghanistan 20210603.8421558
Poliomyelitis update (07): global, Sierra Leone, Kenya, Somalia, WHO 20210527.8382587
Poliomyelitis update (06): global, Africa 20210516.8363867
Poliomyelitis update (05): global, Afghanistan campaign, Yemen 20210419.8313248
Poliomyelitis update (04): global, WPV1, cVDPV 20210312.8242333
Poliomyelitis update (03): global, WPV1, cVDPV 20210309.8236114
Poliomyelitis update (02): global, WPV1, cDPV 20210222.8205197
Poliomyelitis update (01): Pakistan, global (Nigeria, Guinea, Sierra Leone) RFI 20210102.8064119
2020
----
Poliomyelitis update (24): global (WPV1; cVDPV2) 20201229.8053858
COVID-19 update (77): global, polio vacc on hold, new countries, WHO 20200404.7182744
Poliomyelitis update (01): global (WPV1, cVDPV2), Pakistan (KP, SD) 20200103.6869841
2019
----
Poliomyelitis update (106): Pakistan (KP) RFI 20191231.6865382
Poliomyelitis update (01): global 20190104.6241814
2018
----
Poliomyelitis update (62): (Nigeria, Niger) cVDPV2 20181228.6226490
Poliomyelitis update (01): global (Afghanistan) 20180105.5539242
2017
----
Poliomyelitis update (47): Pakistan, global (Congo DR) 20171229.5526565
Poliomyelitis (01): Pakistan (GB), global, RFI 20170314.4898724
and other items in the archives
.................................................mpp/may/ml
</body>
